Tech Company Financing Transactions

PAQ Therapeutics Funding Round

On 7/16/2021, PAQ Therapeutics landed $30 million in Series A funding from Sherpa Healthcare Partners, Huagai Capital and MRL Ventures.

Transaction Overview

Company Name
Announced On
7/16/2021
Transaction Type
Venture Equity
Amount
$30,000,000
Round
Series A
Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
625 Mass Ave. 02-146
Cambridge, MA 02139
USA
Email Address
Overview
PAQ's platform is driven by autophagosome-tethering compounds (ATTECs), small molecules with the potential to catalyze and selectively enhance the degradation of disease-causing entities through autophagy.
Profile
PAQ Therapeutics LinkedIn Company Profile
Social Media
PAQ Therapeutics Company Twitter Account
Company News
PAQ Therapeutics News
Facebook
PAQ Therapeutics on Facebook
YouTube
PAQ Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Nan Ji
  Nan Ji LinkedIn Profile  Nan Ji Twitter Account  Nan Ji News  Nan Ji on Facebook
Co-Founder
Huaixiang Hao
  Huaixiang Hao LinkedIn Profile  Huaixiang Hao Twitter Account  Huaixiang Hao News  Huaixiang Hao on Facebook


 

 

Browse more venture capital transactions:

Prev: 7/16/2021: Teikametrics venture capital transaction
Next: 7/16/2021: Abodu venture capital transaction

 

Share this article

 


About Our Venture Capital Transactions Database

We do our best to report on every notable VC transaction. VC investment data records on this site come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary